Package 71610-971-42

{"route": ["ORAL"], "spl_id": "45236b92-015e-16d3-e063-6394a90a1068", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749"], "spl_set_id": ["45236b7d-3728-1e13-e063-6394a90ad77f"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1800 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-971-42)", "package_ndc": "71610-971-42", "marketing_start_date": "20251203"}], "brand_name": "RANOLAZINE", "product_id": "71610-971_45236b92-015e-16d3-e063-6394a90a1068", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71610-971", "generic_name": "RANOLAZINE", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RANOLAZINE", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA211829", "marketing_category": "ANDA", "marketing_start_date": "20250630", "listing_expiration_date": "20261231"}